Balasa Dinverno & Foltz’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,346
| Closed | -$253K | – | 251 |
|
|
2020
Q1 | $253K | Sell |
5,346
-188
| -3% | -$8.9K | 0.03% | 207 |
|
|
2019
Q4 | $325K | Buy |
5,534
+34
| +0.6% | +$2K | 0.03% | 202 |
|
|
2019
Q3 | $293K | Buy |
5,500
+61
| +1% | +$3.25K | 0.03% | 191 |
|
|
2019
Q2 | $272K | Buy |
5,439
+41
| +0.8% | +$2.05K | 0.03% | 196 |
|
|
2019
Q1 | $282K | Sell |
5,398
-91
| -2% | -$4.75K | 0.03% | 195 |
|
|
2018
Q4 | $262K | Hold |
5,489
| – | – | 0.03% | 185 |
|
|
2018
Q3 | $276K | Hold |
5,489
| – | – | 0.03% | 200 |
|
|
2018
Q2 | $277K | Hold |
5,489
| – | – | 0.04% | 184 |
|
|
2018
Q1 | $268K | Sell |
5,489
-65
| -1% | -$3.17K | 0.04% | 181 |
|
|
2017
Q4 | $246K | Hold |
5,554
| – | – | 0.04% | 190 |
|
|
2017
Q3 | $282K | Hold |
5,554
| – | – | 0.04% | 169 |
|
|
2017
Q2 | $299K | Sell |
5,554
-70
| -1% | -$3.77K | 0.05% | 164 |
|
|
2017
Q1 | $296K | Sell |
5,624
-354
| -6% | -$18.6K | 0.05% | 161 |
|
|
2016
Q4 | $288K | Hold |
5,978
| – | – | 0.05% | 148 |
|
|
2016
Q3 | $322K | Hold |
5,978
| – | – | 0.06% | 128 |
|
|
2016
Q2 | $324K | Sell |
5,978
-77
| -1% | -$4.17K | 0.06% | 129 |
|
|
2016
Q1 | $307K | Hold |
6,055
| – | – | 0.05% | 131 |
|
|
2015
Q4 | $305K | Sell |
6,055
-72
| -1% | -$3.63K | 0.05% | 150 |
|
|
2015
Q3 | $294K | Buy |
6,127
+72
| +1% | +$3.46K | 0.05% | 142 |
|
|
2015
Q2 | $315K | Sell |
6,055
-47
| -0.8% | -$2.45K | 0.05% | 137 |
|
|
2015
Q1 | $352K | Sell |
6,102
-135
| -2% | -$7.79K | 0.05% | 123 |
|
|
2014
Q4 | $333K | Hold |
6,237
| – | – | 0.05% | 135 |
|
|
2014
Q3 | $358K | Hold |
6,237
| – | – | 0.05% | 110 |
|
|
2014
Q2 | $417K | Hold |
6,237
| – | – | 0.05% | 92 |
|
|
2014
Q1 | $417K | Sell |
6,237
-41
| -0.7% | -$2.74K | 0.05% | 89 |
|
|
2013
Q4 | $419K | Sell |
6,278
-32
| -0.5% | -$2.14K | 0.06% | 85 |
|
|
2013
Q3 | $396K | Hold |
6,310
| – | – | 0.07% | 75 |
|
|
2013
Q2 | $394K | Buy |
+6,310
| New | +$394K | 0.07% | 68 |
|